Low Serum Ferroxidase I Activity Is Associated With Mortality in Heart Failure and Related to Both Peroxynitrite-Induced Cysteine Oxidation and Tyrosine Nitration of Ceruloplasmin

被引:31
|
作者
Cabassi, Aderville [1 ,2 ]
Binno, Simone Maurizio [1 ]
Tedeschi, Stefano [1 ]
Ruzicka, Valerie [1 ,2 ]
Dancelli, Simona [1 ,2 ]
Rocco, Rossana [1 ]
Vicini, Vanni [4 ]
Coghi, Pietro [1 ,2 ]
Regolisti, Giuseppe [1 ]
Montanari, Alberto [1 ,2 ]
Fiaccadori, Enrico [1 ]
Govoni, Paolo [3 ]
Piepoli, Massimo [5 ]
de Champlain, Jacques [6 ]
机构
[1] Univ Parma Med Sch, Cardiorenal Res Unit, Parma, Italy
[2] Univ Parma Med Sch, Lab Expt Physiopathol, Parma, Italy
[3] Univ Parma Med Sch, Histol & Embriol Unit, Dept Biomed Biotechnol & Translat Sci S Bi Bi T, Parma, Italy
[4] Azienda Osped Univ Parma, Cardiol Clin, Parma, Italy
[5] Guglielmo Saliceto Polichirurg Hosp, Dept Cardiol, Piacenza, Italy
[6] Univ Montreal, Inst Rech Clin Montreal, Montreal, PQ, Canada
关键词
ceruloplasmin; heart failure; mortality; oxidative stress; HYPERTENSIVE-RATS; NITRIC-OXIDE; PLASMA-PROTEINS; RISK; DYSFUNCTION; MODULATION; REACTIVITY; GUIDELINES; DIAGNOSIS; STRESS;
D O I
10.1161/CIRCRESAHA.114.302849
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale: Ceruloplasmin antioxidant function is mainly related to its ferroxidase I (FeOxI) activity, which influences iron-dependent oxidative and nitrosative radical species generation. Peroxynitrite, whose production is increased in heart failure (HF), can affect ceruloplasmin antioxidant function through amino acid modification. Objective: We investigated the relationship between FeOxI and ceruloplasmin tyrosine and cysteine modification and explored in a cohort of patients with HF the potential clinical relevance of serum FeOxI. Methods and Results: In patients with chronic HF (n=96, 76 +/- 9 years; New York Heart Association class, 2.9 +/- 0.8) and age-matched controls (n=35), serum FeOxI, FeOxII, ceruloplasmin, nitrotyrosine-bound ceruloplasmin, B-type natriuretic peptide, norepinephrine, and high-sensitivity C-reactive protein were measured, and the patients were followed up for 24 months. Ceruloplasmin, B-type natriuretic peptide, norepinephrine, and high-sensitivity C-reactive protein were increased in HF versus controls. FeOxI was decreased in HF (-20%) and inversely related to nitrotyrosine-bound ceruloplasmin (r, -0.305; P=0.003). In HF, FeOxI lower tertile had a mortality rate doubled compared with middle-higher tertiles. FeOxI emerged as a mortality predictor (hazard ratio, 2.95; 95% confidence intervals [1.29-6.75]; P=0.011) after adjustment for age, sex, hypertension, smoking, sodium level, estimated glomerular filtration rate, and high-sensitivity C-reactive protein. In experimental settings, peroxynitrite incubation of serum samples and isolated purified ceruloplasmin reduced FeOxI activity while increasing ceruloplasmin tyrosine nitration and cysteine thiol oxidation. Reduced glutathione prevented peroxynitrite-induced FeOxI drop, tyrosine nitration, and cysteine oxidation; flavonoid(-)-epicatechin, which prevented ceruloplasmin tyrosine nitration but not cysteine oxidation, partially impeded peroxynitrite-induced FeOxI drop. Conclusions: Reduced activity of serum FeOxI is associated with ceruloplasmin nitration and reduced survival in patients with HF. Both ceruloplasmin tyrosine nitration and cysteine thiol oxidation may be operant in vivo in peroxynitrite-induced FeOxI activity inhibition.
引用
收藏
页码:1723 / +
页数:14
相关论文
empty
未找到相关数据